Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2021-05-10 (4 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-LEGER-SOUS-CHOLET (49280), Maine-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SAINT LEGEOISE : revenue, balance sheet and financial ratios
PHARMACIE SAINT LEGEOISE is a French company
founded 4 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-LEGER-SOUS-CHOLET (49280),
this company of category PME
shows in 2025 a net income positive of 129 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT LEGEOISE (SIREN 899177000)
Indicator
2025
2024
2023
2022
Revenue
N/C
N/C
N/C
N/C
Net income
128 791 €
150 622 €
177 661 €
100 062 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE SAINT LEGEOISE generates positive net income of 129 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 100 k€ -> 129 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
128 791 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 105%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
105.219%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.006%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINT LEGEOISE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
2024
2025
Debt ratio
893.312
317.061
192.219
105.219
Financial autonomy
8.615
20.032
31.014
42.006
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
105.222025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-8 pts over 3 years
In 2025, the debt ratio of PHARMACIE SAINT LEGEOISE (105.22) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.01%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+11 pts over 3 years
In 2025, the financial autonomy of PHARMACIE SAINT LEGEOISE (42.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 233.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
233.683
Liquidity indicators evolution PHARMACIE SAINT LEGEOISE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
2024
2025
Liquidity ratio
202.239
214.387
371.363
233.683
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
233.682025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE SAINT LEGEOISE (233.68) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE SAINT LEGEOISE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE SAINT LEGEOISE is estimated at
2 045 860 €
(range 1 388 330€ - 3 210 236€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1388k€2045k€3210k€
2 045 860 €Range: 1 388 330€ - 3 210 236€
NAF 5 année 2025
Valuation method used
Net Income Multiple
128 791 €
×
15.9x
=2 045 860 €
Range: 1 388 330€ - 3 210 237€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT LEGEOISE with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT LEGEOISE
What is the revenue of PHARMACIE SAINT LEGEOISE ?
The revenue of PHARMACIE SAINT LEGEOISE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE SAINT LEGEOISE profitable?
Yes, PHARMACIE SAINT LEGEOISE generated a net profit of 129 k€ in 2025.
Where is the headquarters of PHARMACIE SAINT LEGEOISE ?
The headquarters of PHARMACIE SAINT LEGEOISE is located in SAINT-LEGER-SOUS-CHOLET (49280), in the department Maine-et-Loire.
Where to find the tax return of PHARMACIE SAINT LEGEOISE ?
The tax return of PHARMACIE SAINT LEGEOISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT LEGEOISE operate?
PHARMACIE SAINT LEGEOISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart